Actively Recruiting
Microbiome in Atopic Dermatitis Under Systemic Therapy
Led by Charite University, Berlin, Germany · Updated on 2025-02-13
600
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The skin microbiome plays a role in the pathogenesis of atopic dermatitis. However, it is unclear whether the range of microbiota on the skin is the cause or consequence of atopic skin inflammation. The influence of new systemic therapies for the treatment of moderate to severe atopic dermatitis (such as biologics or Janus kinase inhibitors) on the skin microbiome is largely unknown. The main aim of this scientific exploratory study is to investigate whether and how the skin microbiome changes in patients with moderate to severe atopic dermatitis during systemic therapy. This not only allows new hypotheses to be generated on the pathogenesis of atopic dermatitis, but also new objective scales for the severity of atopic dermatitis can be developed.
CONDITIONS
Official Title
Microbiome in Atopic Dermatitis Under Systemic Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with moderate to severe atopic dermatitis
- Indication for systemic therapy
You will not qualify if you...
- Patients under 18 years of age upon introducing systemic therapy
- Pregnant and lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dpt of Dermatology and Allergology, Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 10117
Actively Recruiting
Research Team
M
Margitta Worm, Prof
CONTACT
S
Sabine Dölle-Bierke, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here